Demographic Factors Tied to Differences in Long COVID Symptoms
By Lori Solomon HealthDay Reporter
FRIDAY, Aug. 30, 2024 -- Demographic factors significantly influence long COVID symptom severity, according to a study published online Aug. 28 in JRSM Open.
David Sunkersing, Ph.D., from University College London, and colleagues investigated long COVID symptoms self-reported (Nov. 30, 2020, to March 23, 2022) via a digital application from 1,008 individuals.
The researchers found that among the 109 reported symptom categories, pain (26.5 percent), neuropsychological issues (18.4 percent), fatigue (14.3 percent), and dyspnea (7.4 percent) were the most prevalent. Per month since registration, the intensity of reported symptoms increased by 3.3 percent. Compared with those aged 18 to 27 years, those aged 68 to 77 years and those 78 to 87 years experienced higher symptom intensity (32.8 percent and 86 percent higher, respectively). Compared with men, women reported 9.2 percent more intense symptoms, and non-White individuals reported 23.5 percent more intense symptoms than White participants. Higher education levels were associated with less symptom intensity versus the lowest education levels (range: 27.7 to 62.8 percent less intense). Similarly, people residing in less deprived areas had less intense symptoms versus those in the most deprived areas.
"With ongoing occurrences of COVID-19 (e.g., LB.1, or D-FLiRT variants), the potential for more long COVID cases remains a pressing concern," Sunkersing said in a statement. "Our findings can help shape targeted interventions and support strategies for those most at risk."
Two authors disclosed ties to Living With Ltd.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Further Support and Information on COVID-19
Read this next
Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections
WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.